首页> 外国专利> Compounds and their processes for the preparation, use and pharmaceutical formulations and methods for preventing and / or treating mglur5 receptor mediated disorders and inhibiting mglu r5 receptor activation.

Compounds and their processes for the preparation, use and pharmaceutical formulations and methods for preventing and / or treating mglur5 receptor mediated disorders and inhibiting mglu r5 receptor activation.

机译:用于预防和/或治疗mglur5受体介导的疾病并抑制mglu r5受体活化的化合物及其制备,用途,药物制剂和方法。

摘要

"COMPOUNDS AND THEIR PROCESS FOR PREPARATION, USE AND PHARMACEUTICAL FORMULATIONS AND METHODS FOR PREVENTION AND / OR TREATMENT OF MGLUR5 RECEIVER MEDIA AND INHIBITION OF MGLUR5 RECEIVER ACTIVATION". The present invention relates to novel compounds of formula (I), a process for their preparation and new intermediates prepared therein, to pharmaceutical formulations containing said compounds and to the use of said compounds in therapy. In particular, there are compounds according to the present invention which are potent and selective for mGluR Group I receptor and more particularly for mGluR5. Thus, the compounds of the invention are expected to be well suited for the prevention and / or treatment of mGluR5 receptor mediated disorders, such as acute and chronic neurological and psychiatric disorders and acute painful disorders.
机译:“用于预防和/或治疗MGLUR5接收介质和抑制MGLUR5接收器活化的化合物,其制备,使用和药物制剂的方法以及方法和方法”。本发明涉及式(I)的新化合物,其制备方法和其中制备的新中间体,涉及包含所述化合物的药物制剂以及所述化合物在治疗中的用途。特别地,存在根据本发明的化合物,其对mGluR I组受体,特别是对mGluR5有效且具有选择性。因此,预期本发明的化合物非常适合预防和/或治疗mGluR5受体介导的疾病,例如急性和慢性神经和精神疾病以及急性疼痛性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号